NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)
- Response deadline
- Sep 3, 2026 Closed
- Date posted
- Jun 29, 2026
- Source
- Open notice
Description
The NIH Director"s Transformative Research Award supports individual scientists or groups of scientists proposing bold, groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Applications in any area within the biomedical sciences are welcome; topics may involve basic, translational, or clinical research. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in a broad area of relevance to the NIH. The NIH Director"s Transformative Research Award is a component of the High-Risk, High-Reward Research (HRHR) program of the NIH Common Fund.
Classifications
- NAICS93.310
Documents (1)
- RFA-RM-27-003-Full-Announcement.htmltext/html;charset=UTF-8120 KBNot yet available
Contacts
Similar contracts
- Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)Due Jan 8, 2027
- Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)Due Jan 8, 2027
- Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trial Not Allowed)Due Jan 8, 2027
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)Due Jan 29, 2027
- Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)Due Nov 23, 2026
- Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)Due Nov 23, 2026